A phase I study of thymoglobulin for relapsed or refractory multiple myeloma
Leuk Lymphoma
.
2016 Feb;57(2):453-455.
doi: 10.3109/10428194.2015.1049170.
Epub 2015 Jun 19.
Authors
Jesse Keller
1
,
Mark A Fiala
1
,
John Dipersio
1
,
Keith Stockerl-Goldstein
1
,
Ravi Vij
1
,
Coy D Heldermon
2
Affiliations
1
a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
2
b Division of Oncology, Department of Medicine , University of Florida Shands Cancer Center , FL , USA.
PMID:
25971909
DOI:
10.3109/10428194.2015.1049170
No abstract available